The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The federal government has widened its probe of prescription drug maker Johnson & Johnson for its marketing practices. Specifically, the company is coming under further scrutiny for its antipsychotic Risperdal; Topamax, a treatment for epilepsy and migraines; and Natrecor, for patients suffering from severe heart failure.

Comments are closed.

Of Interest